COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices

Zijun Wang,Hui Liu,Yang Li,Xufei Luo,Nan Yang,Meng Lv,Qi Zhou,Qinyuan Li,Ling Wang,Junxian Zhao,Yunlan Liu,Renfeng Su,Shouyuan Wu,Xiao Liu,Siya Zhao,Qianling Shi,Janne Estill,Xingrong Liu,Wenhong Zhang,Yaolong Chen

DOI: https://doi.org/10.1016/j.jclinepi.2021.12.015

IF: 7.407

2022-01-01

Journal of Clinical Epidemiology

Abstract:Objective: To describe the current status of COVID-19 vaccine guidelines. Study Design and Setting: We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines and extract data of whether the methodology, funding, and conflict of interests were assessed/reported, and so on. Results were presented descriptively. Results: A total of 106 COVID-19 vaccine guidelines were included. In the first half of 2021, on average 15 guidelines were published every month. Fifty (47.2%) guidelines addressed the vaccination of people with specific medical conditions, and 18 (17.0%) guidelines focused on adverse effects after vaccination. Only 28 (26.4%) guidelines reported the methodology they used. Four (3.8%) of guidelines assessed both the quality of evidence and strength of recommendations; 42 (39.6%) and 65 (61.3%) guidelines reported their funding sources and conflict of interest, respectively. Most guidelines were published in English (n = 92, 86.8%). Conclusion: A high number of guidelines on COVID-19 vaccines have been published in the recent months, but most of them lack clear and transparent reporting of methodology, funding, and conflicts of interest. Rigorous methodological and reporting quality evaluation of these guidelines is needed. (C) 2021 The Author(s). Published by Elsevier Inc.